A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission. . . . → Read More: DoD Funds Covid-19 G.I. Infection Therapy
|
|||||
|
       
  |
A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its second venture funding round. . . . → Read More: Chip-Based RNA Biotech Raises $60M in Venture Funds 
Researchers in the U.K. created a bandage with enhanced human skeletal stem cells that in lab mice repairs simulated skull defects. . . . → Read More: Skeletal Stem Cells Enhanced for Bone Repair 
A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $127.5 million in its initial public stock offer. . . . → Read More: Mental Health Drug Company Raises $127.5M in IPO 
Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editing treatments for cystic fibrosis. . . . → Read More: Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy 
First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19 
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds 
Gilead Sciences is acquiring biotechnology company Immunomedics, specializing in immunotherapies for cancer and other diseases, in a deal valued at $21 billion. . . . → Read More: Gilead Acquires Cancer Therapy Biotech for $21B 
National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections. . . . → Read More: NIH Trials Testing Covid-19 Blood Clot Therapies  Comments are closed  Joint ventures/collaborations, New products  biomedical, clinical trials, Covid-19, life sciences, NIH, pharmaceuticals, university 
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments. . . . → Read More: Antibody Discovery Company Forms, Partners on Covid-19 Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, Covid-19, engineering, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||